It could be a feather in the cap, however they aren't a big player in the scheme of medical product distribution. Their annual revenues apparently $5Million compared to our deal with Henry Schein whose annual revenues are $12B.
In the US, it would be good to see some distribution deals with the likes of Medline, Cardinal Health or McKesson who all have substantial market caps and involvement in the wholesale medical supply industries.
LDX Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
